Delivery of immunogens to mucosal immune system using an oral inactivated cholera vaccine

References

• McGhee JR. A mucosal gateway for vaccines. Nat Biotechnol 2011; 29:136 - 8; http://dx.doi.org/10.1038/nbt.1766; PMID: 21301439
   PubMedGoogle Scholar
• McGhee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M, Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992; 10:75 - 88; http://dx.doi.org/10.1016/0264-410X(92)90021-B; PMID: 1539467
   PubMed Web of Science ®Google Scholar
• McGhee JR, Kiyono H. Mucosal immunity to vaccines: current concepts for vaccine development and immune response analysis. Adv Exp Med Biol 1992; 327:3 - 12; http://dx.doi.org/10.1007/978-1-4615-3410-5_2; PMID: 1295349
   PubMedGoogle Scholar
• Azizi A, Ghunaim H, Diaz-Mitoma F, Mestecky J. Mucosal HIV vaccines: a holy grail or a dud?. Vaccine 2010; 28:4015 - 26; http://dx.doi.org/10.1016/j.vaccine.2010.04.018; PMID: 20412879
   PubMedGoogle Scholar
• Azizi A, Kumar A, Diaz-Mitoma F, Mestecky J. Enhancing oral vaccine potency by targeting intestinal M cells. PLoS Pathog 2010; 6:e1001147; http://dx.doi.org/10.1371/journal.ppat.1001147; PMID: 21085599
   PubMed Web of Science ®Google Scholar
• Parr EL, Parr MB. A comparison of antibody titres in mouse uterine fluid after immunization by several routes, and the effect of the uterus on antibody titres in vaginal fluid. J Reprod Fertil 1990; 89:619 - 25; http://dx.doi.org/10.1530/jrf.0.0890619; PMID: 2401988
   PubMedGoogle Scholar
• Katz DE, DeLorimier AJ, Wolf MK, Hall ER, Cassels FJ, van Hamont JE, et al. Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen. Vaccine 2003; 21:341 - 6; http://dx.doi.org/10.1016/S0264-410X(02)00613-8; PMID: 12531630
   PubMed Web of Science ®Google Scholar
• Frey A, Giannasca KT, Weltzin R, Giannasca PJ, Reggio H, Lencer WI, et al. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J Exp Med 1996; 184:1045 - 59; http://dx.doi.org/10.1084/jem.184.3.1045; PMID: 9064322
   PubMed Web of Science ®Google Scholar
• Italia JL, Kumar MN, Carter KC. Evaluating the potential of polyester nanoparticles for per oral delivery of amphotericin B in treating visceral leishmaniasis. J Biomed Nanotechnol 2012; 8:695 - 702; http://dx.doi.org/10.1166/jbn.2012.1414; PMID: 22852479
   PubMed Web of Science ®Google Scholar
• Mann JF, Scales HE, Shakir E, Alexander J, Carter KC, Mullen AB, et al. Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity. Methods 2006; 38:90 - 5; http://dx.doi.org/10.1016/j.ymeth.2005.11.002; PMID: 16414269
   PubMed Web of Science ®Google Scholar
• Shukla A, Katare OP, Singh B, Vyas SP. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes. Int J Pharm 2010; 385:47 - 52; http://dx.doi.org/10.1016/j.ijpharm.2009.10.027; PMID: 19835938
   PubMed Web of Science ®Google Scholar
• Shukla A, Khatri K, Gupta PN, Goyal AK, Mehta A, Vyas SP. Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes). J Pharm Pharm Sci 2008; 11:59 - 66; PMID: 18445364
   PubMed Web of Science ®Google Scholar
• Rescia VC, Takata CS, de Araujo PS, Bueno da Costa MH. Dressing liposomal particles with chitosan and poly(vinylic alcohol) for oral vaccine delivery. J Liposome Res 2011; 21:38 - 45; http://dx.doi.org/10.3109/08982101003735988; PMID: 20470223
   PubMed Web of Science ®Google Scholar
• van der Lubben IM, Verhoef JC, van Aelst AC, Borchard G, Junginger HE. Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer’s patches. Biomaterials 2001; 22:687 - 94; http://dx.doi.org/10.1016/S0142-9612(00)00231-3; PMID: 11246962
   PubMed Web of Science ®Google Scholar
• Lambert JS, Keefer M, Mulligan MJ, Schwartz D, Mestecky J, Weinhold K, et al. A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects. Vaccine 2001; 19:3033 - 42; http://dx.doi.org/10.1016/S0264-410X(01)00051-2; PMID: 11311997
   PubMed Web of Science ®Google Scholar
• Wright PF, Mestecky J, McElrath MJ, Keefer MC, Gorse GJ, Goepfert PA, et al, National Institutes of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein. J Infect Dis 2004; 189:1221 - 31; http://dx.doi.org/10.1086/382088; PMID: 15031791
   PubMed Web of Science ®Google Scholar
• Azizi A, Anderson DE, Torres JV, Ogrel A, Ghorbani M, Soare C, et al. Induction of broad cross-subtype-specific HIV-1 immune responses by a novel multivalent HIV-1 peptide vaccine in cynomolgus macaques. J Immunol 2008; 180:2174 - 86; PMID: 18250424
   PubMed Web of Science ®Google Scholar
• Ghunaim H, Kumar A, Torres J, Diaz-Mitoma F, Azizi A. An immunological comparison between lipidated and non-lipidated multivalent HIV-1 peptides representing Gp120 and Gag hypervariable regions. Vaccine 2011; 29:5950 - 8; http://dx.doi.org/10.1016/j.vaccine.2011.06.047; PMID: 21718739
   PubMedGoogle Scholar
• Jelinek T, Kollaritsch H. Vaccination with Dukoral against travelers’ diarrhea (ETEC) and cholera. Expert Rev Vaccines 2008; 7:561 - 7; http://dx.doi.org/10.1586/14760584.7.5.561; PMID: 18564011
   PubMed Web of Science ®Google Scholar
• Bunyakul N, Edwards KA, Promptmas C, Baeumner AJ. Cholera toxin subunit B detection in microfluidic devices. Anal Bioanal Chem 2009; 393:177 - 86; http://dx.doi.org/10.1007/s00216-008-2364-6; PMID: 18777170
   PubMedGoogle Scholar
• Hase K, Kawano K, Nochi T, Pontes GS, Fukuda S, Ebisawa M, et al. Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response. Nature 2009; 462:226 - 30; http://dx.doi.org/10.1038/nature08529; PMID: 19907495
   PubMed Web of Science ®Google Scholar
• Bauer S, Müller T, Hamm S. Pattern recognition by Toll-like receptors. Adv Exp Med Biol 2009; 653:15 - 34; http://dx.doi.org/10.1007/978-1-4419-0901-5_2; PMID: 19799109
   PubMedGoogle Scholar
• Kirschning CJ, Bauer S. Toll-like receptors: cellular signal transducers for exogenous molecular patterns causing immune responses. Int J Med Microbiol 2001; 291:251 - 60; http://dx.doi.org/10.1078/1438-4221-00128; PMID: 11680785
   PubMed Web of Science ®Google Scholar